Aspiriant LLC’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Aspiriant LLC's MDT Position: Q3 2026 in Review
Aspiriant LLC reduced its Medtronic (MDT) stake by 40% in Q3 2026, selling an estimated $204K and leaving 3,450 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #319.
Aspiriant LLC first reported a position in MDT in Q1 2018 and has held it in 17 quarters since. The position peaked at $482K in Q1 2026. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Aspiriant LLC held 3,450 shares of Medtronic worth $298K as of Q3 2026.
- Aspiriant LLC sold 2,320 Medtronic shares in Q3 2026, an estimated $204K.
- Medtronic made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #319 holding.
- Aspiriant LLC first reported a position in Medtronic in Q1 2018 and has held it in 17 quarters since.
- Aspiriant LLC's Medtronic position peaked at $482K in Q1 2026.
- 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.